<SEC-DOCUMENT>0001600620-24-000074-index.html : 20240522
<SEC-HEADER>0001600620-24-000074.hdr.sgml : 20240522
<ACCEPTANCE-DATETIME>20240522161131
ACCESSION NUMBER:		0001600620-24-000074
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20240521
FILED AS OF DATE:		20240522
DATE AS OF CHANGE:		20240522

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Jayne David R.W.
		CENTRAL INDEX KEY:			0001838242
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36421
		FILM NUMBER:		24973353

	MAIL ADDRESS:	
		STREET 1:		#1203-4464 MARKHAM STREET
		CITY:			VICTORIA
		STATE:			A1
		ZIP:			BC V8Z7X8

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Aurinia Pharmaceuticals Inc.
		CENTRAL INDEX KEY:			0001600620
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				981231763
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		#140, 14315 - 118 AVENUE
		CITY:			EDMONTON
		STATE:			A0
		ZIP:			T5L 4S6
		BUSINESS PHONE:		250-744-2487

	MAIL ADDRESS:	
		STREET 1:		#140, 14315 - 118 AVENUE
		CITY:			EDMONTON
		STATE:			A0
		ZIP:			T5L 4S6
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>wk-form4_1716408679.xml
<DESCRIPTION>FORM 4
<TEXT>
Document 1 - file: wk-form4_1716408679.html

Document 1 - RAW XML: wk-form4_1716408679.xml

</DOCUMENT>
</SEC-DOCUMENT>